Skip to content

Bilateral Lateral OFC rTMS in Obsessive Compulsive Disorder

A Randomized Control Trial of Bilateral Lateral OFC rTMS in Obsessive Compulsive Disorder

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04934007
Acronym
ORBITOC3
Enrollment
136
Registered
2021-06-22
Start date
2021-09-06
Completion date
2027-09-30
Last updated
2026-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obsessive-Compulsive Disorder

Keywords

rTMS, D-B80 A/P

Brief summary

According to the literature the lateral part of the Orbito Frontal Cortex (lOFC) is a relevant bilateral target for repetitive Trans-cranial Magnetic Stimulation (rTMS) in Obsessive Compulsive Disorder (OCD). Both hemispheres are concerned in terms of target.

Interventions

1 Hz rTMS

Sponsors

Centre Hospitalier Henri Laborit
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Age: Participants will be both males and females, 18-65 years of age included. * diagnosis of OCD * all the patients must have failed to respond to at least two different pharmacological treatment used for at least 6 weeks * Affiliation to a social security system (recipient or assignee), * Signed written inform consent form

Exclusion criteria

* The

Design outcomes

Primary

MeasureTime frameDescription
Yale Brown Obsessive Compulsive Scale scorebaseline and 25 daysSignificant clinical change (≥ 25%) from baseline to two weeks after the treatment sequence, assessed by a significant reduction in YBOCS scores at day 25

Secondary

MeasureTime frameDescription
Yale Brown Obsessive Compulsive Scalebaseline and 70 daysSignificant clinical change of the YBOCS score (≥25% decrease), from baseline to day 70
general assessement functioning (GAF)baseline and 25 daysChange of the general assessement functioning (GAF) at day 25
Clinical Global Impression (CGI)baseline and 25 daysClinical Global Impressions (CGI) change at day 25
Adverse events linked to the rTMS treatment70 daysNumber and types of adverse events linked to the rTMS treatment

Countries

France

Contacts

Primary ContactGhina Harika-Germaneau, MD, PhD
ghina.harika.germaneau@ch-poitiers.fr+33 5 16 52 61 18
Backup ContactNematollah Jaafari, PR
nemat.jaafari@ch-poitiers.fr+33 5 16 52 61 18

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026